Why the study?
The study sought to evaluate the incidence of cerebrovascular events in Brugada syndrome and analyze predictors, clinical characteristics, and prognosis of cardioembolic events secondary to atrial fibrillation.
Patients with Brugada syndrome and atrial fibrillation have an unexpectedly high risk of cardioembolic stroke that is not accurately predicted by standard CHA2DS2-VASc scores.
No takes yet. Share an insight, caveat, or question.
High stroke incidence in BrS with AF despite low CHA2DS2-VASc scores warrants vigilance; leaves open need for prospective anticoagulation trials.
Asmundis et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: